PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home » Blogs » Couch in Crisis

Psychiatric Times.
 

DSM-5 Will Further Inflate the ADD Bubble: Child Work Group Fails to Learn From Experience

By Allen Frances, MD | July 27, 2011

Martin Whiteley is an MP who represents Perth in the Australian parliament. He has been actively involved in mental health issues and succeeded in a crusade to curb what had been Perth's alarming overdiagnosis and overmedication of Attention Deficit Disorder (ADD). Mr Whiteley has become expert in the intricacies of  ADD and is alarmed that the changes suggested for DSM 5 will greatly exacerbate the ADD fad he worked so hard to tame.  Read Mr Whiteley's careful item by item review and you will be alarmed, too (See:  http://speedupsitstill.com/dsm-5-proposal-adhd-%e2%80%93-making-lifelong-pat).   

 We are already in the midst of a false epidemic of ADD. Rates in kids that were 3-5% when DSM IV was published in 1994 have now jumped to 10%. In part this came from changes in DSM IV, but most of the inflation was caused by a marketing blitz to practitioners that accompanied new on-patent drugs amplified by new regulations that also allowed direct to consumer advertising to parents and teachers. In a sensible world, DSM 5 would now offer much tighter criteria for ADD and much clearer advice on the steps needed in its differential diagnosis. This would push back ,however feebly, against the skilled and well financed drug company sell. DSM 5 should work hard to improve its text, not play carelessly with the ADD criteria in a way that may unleash a whole set of dreadful unintended consequences- unneeded medication, stigma, lowered expectations, misallocation of resources, and contribution to the illegal secondary market peddling stimulants for recreation or performance enhancement.

The DSM 5 child and adolescent work group has perversely gone just the other way. It proposes to make an already far too easy diagnosis much looser.

How puzzling and troubling. Child mental health has already promoted no fewer than three false  epidemics in just 15 years- ADD, childhood bipolar, and autism. Any reasonable group would now be learning from this past experience. For the future, it would be chastened, cautious, and eager to correct the damage it has done- rather than embarking on any reckless new adventures. A prudent DSM 5 would tighten its criteria for ADD and put in a black box warning against the blatant current  off-the-DSM-label diagnosis of childhood bipolar.  DSM 5 instead does everything wrong it possibly could with ADD and then remarkably takes the mischievous further step of adding yet another new candidate for diagnostic fad (Disruptive Mood Dysregulation Disorder) likely that will increase the already scandalous overprescription of  dangerous antipsychotic medication to children. Go figure.

In many circles, the accepted wisdom is that DSM 5 workers are making such unaccountably bad decisions because they want to promote drug sales to kids. To support this accusation, cynics raise the Biederman affair and also APA's previous excessive financial support from Pharma.

This is one time when the cynics are dead wrong. The DSM 5 work group is making simply disastrous decisions for the purist of reasons. These are not people with close industry ties and their conflict of interest is intellectual, not financial. Experts in child psychiatry are dangerously naïve about the likely misuses of their well meaning suggestions. They are blind, not corrupt.

What is needed is outside supervision to curb child psychiatry's seemingly endless taste for diagnostic excess. And APA should also realize the grave  harm done to its credibility by the appearance that DSM 5 is far too Pharma friendly even if this has not been the real motivation behind the bad DSM 5 proposals.     

To make matters worse, the DSM 5 field trial will be completely worthless- providing no information at all about the magnitude of the rate increase in ADD that will occur once DSM 5 opens the floodgates even wider. We did careful field trials before DSM IV to compare the impact on rates of the  different possible definitions and predicted a 15% increase for the one finally chosen. Instead, the rates more than doubled- courtesy of pressure from the drug companies. For obscure reasons, DSM 5 is conducting extraordinarily expensive field trials that (again perversely) avoid the only question that really counts- just how high will the rates skyrocket under the even easier to meet new DSM 5 definition.

DSM 5 will be flying completely blind into dangerous territory, unimpeded by adult supervision. The leaders of child psychiatry (who already have the unfortunate  track record of producing fads) will now be given a free pass to further feed their blossoming ADD fad. Will they never learn from past mistakes?

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Manuel Mota-Castillo | August 29, 2011 8:29 PM EDT

A necessary correction to my "question to Dr. Frances."
A very good friend that read my previous posting noticed that where it says "raises dopamine"should obviously say decreases dopamine in the brain. I am grateful for the warning and also want to use the opportunity to clarify that I have seen the Parkinsonism caused by the dopamine blockers but I am a firm believer that in medicine we are faced every day with having to choose between the lesser of two evils: providing a treatment with known side effects or allowing an illness to run its course.
Finally, it occurs to me to ask this question to all Psychiatric Times readers: Would you go for an evaluation of a headache to a neurologist that has a "Meningioma Clinic" and is known for diagnosing 99% of his or her patient with a meningioma? I doubt that a reasonable person will. Still, when it comes to childhood emotional problems, this happens every day. We even forget about DSM-IV and look the other way when a child with Mental Retardation or Autism is given stimulants for ADHD even though we don't the APA's manual to understand that children with below average IQ or Autism spectrum disorders have a clear justification for lacking attention and their symptoms are exacerbated by the elevation of dopamine levels. I hope that the fact that obsessive traits are worsened by this substance.

Manuel Mota-Castillo, M.D.

by Manuel Mota-Castillo | August 29, 2011 6:16 PM EDT

A question for Dr. Frances:
I should start by expressing my gratitude for your consistent position against the trivialization of the DSM-V development. You are also correct in denouncing two false epidemics (ADHD and Autism) but, in my opinion, you lack evidence to prove that we don't have a significant amount of cases of bipolar disorder in children. I am even surprised that a scientist of your level could doubt what seems obvious to a blue collar worker who is raising his grandson and asked me this question: "The pediatrician says my boy has ADHD but my daughter is bipolar like her mother and the father…well we don't who he is. Don't you think that his mood swings are the same one that I noticed in my daughter when she was his age?"
As an inpatient psychiatrist I see a daily flow of children and adolescents with violent behaviors, insomnia, hypersexuality, irritability and several other symptoms and signs that are contraindications for amphetamines still taking medications for ADHD "with Oppositional-Defiant Disorder."They are usually in a waiting list to be placed in a Residential Treatment Center "because they have failed to respond to "proven" treatment when the reality is that doctors and therapists have ignored a basic rationale: amphetamines worsen aggressive behavior. More questionable yet, some of those children are having auditory hallucinations and still taking methylphenidate or amphetamines. When I react with surprise they usually respond: "the doctors never asked me about voices."
I also have an experience that I want to share with you, Dr. Frances. As a First Year Resident in Pediatrics and rotated through the Neonatal Intensive Care Unit and had the opportunity of giving dopamine to babies in septic shock, many of which survived. That was pure dopamine, not risperidone that raises the level of dopamine in the brain. This is why I can't comprehend how such a brilliant mind like yours could be distressed by the use of antipsychotic medications in children and not by the administration of dopamine to babies. I certainly don't believe in the perennial use of this type of drugs but a brief trial to abort a manic episode it is biologically safe and psychologically preventive. I say so because when a child or adolescent is allowed to be the "black sheep" "the one to stay away from" there is long-lasting injury to his or her self-esteem.
Now, Dr. Frances, let's call things by their names. What kind of diagnosis would you give to a toddler that never takes nap, hits and bites without provocation, destroys things and is cruel with animals…and both parents are bipolar? Terrible Twos? If that is the case would the label be "Terrible Threes" a year later?
Pediatric oncologists diagnose cancer in little children but psychiatrists are bad mouthed when we give a "bad label" to a child that could have a normal life with the appropriate treatment. What is wrong with this picture? This is my question to you, admired and respected Dr. Frances!

by Dr Charles Parker | August 15, 2011 4:10 AM EDT

ADHD is a false epidemic when the criteria for diagnosis are so vague as to render diagnostic precision impossible. Diagnosis by appearances is not in keeping with modern neuroscientific principles. Hyperactive, inattentive and combined invite this kind of justifiable criticism from thoughtful mind watchers. With these vagaries Dr Frances remains absolutely correct in his terminology, incorrect in missing the real ADHD epidemic that exists dynamically, beyond simple static labels.

I can report without hesitation from my everyday office perspective that many simply are not paying attention to the essential details in diagnosis and psychopharmacology - the remarkable insights in neuroscience. ADHD treatment is a circus, a whimsical parade of cookie cutters solutions that do little to identify and treat targets associated with actual brain function. In that regard I completely agree with the observation that DSM 5 thinkers are well meaning, but completely antique in their thinking.

by Anthony Ocana | August 12, 2011 7:20 PM EDT

Ask any child who can't pay attention, even when he wants to, whether ADHD is a false epidemic. Ask Dr. Kessler, the world famous epidemiologist whether ADHD is a false epidemic. Look at the rates of smoking, motor vehicle accidents, adolescent pregnancy and academic failure and you will see that they do not change with all the education in the world. Look how the rates drop when you treat the underlying ADHD and you will see that it is a disorder worth recognizing and treating. There is nothing controversial about it. Read the data, not the editorials.






 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • Grief and Depression: The Sages Knew the Difference
  • The Moral Struggles of Practicing Psychiatrists
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • An Update on ADHD
  • Eco-Psychiatry: Why We Need to Keep the Environment in Mind
  • DSM-5: Where Do We Go From Here?
  • Suicidal Behavior: A Separate Diagnosis
  • New Insight Into the Neurobiology of Depression
  • Cultural Psychiatry and the 'No-Chicken' Doctor
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • Diagnosis and its Discontents: The DSM Debate Continues
  • Lamotrigine for Major Depressive Disorder Is Inappropriate
  • Psychiatry and the Myth of “Medicalization”
  • Parity Laws: Powerful Weapon—or Pipe Dream?
  • The Moral Struggles of Practicing Psychiatrists
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • NIMH vs DSM 5: No One Wins, Patients Lose
Click here to subscribe to our newsletter


 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy